-transparent.png){kind=logo}
Thirty-two cases of xeroderma pigmentosum (XP) of the complementation groups C (7), D (12), E (3), I (2) and 8 variants are analyzed biochemically and clinically. There is some congruence of the cellular defects (UDS, CFA, SCE) and the clinical severity of the skin symptoms. Despite the large clinical variability within and between the complementation groups, several clinical features are to be attributed to one group or another. The most striking observation is the predominance of LMM in the D group and BCC in the mild E group as well as in the variants. This observation might stimulate research to find a cellular characteristic of the melanoma risk.
Related Publications
E G Jung, and
E Bohnert, and
E Fischer
February 1989,
Human genetics,
E G Jung, and
E Bohnert, and
E Fischer
January 1992,
Mutation research,
E G Jung, and
E Bohnert, and
E Fischer
October 1984,
Photo-dermatology,
E G Jung, and
E Bohnert, and
E Fischer
December 1989,
Human genetics,
E G Jung, and
E Bohnert, and
E Fischer
December 1975,
Mutation research,
E G Jung, and
E Bohnert, and
E Fischer
December 2013,
The British journal of dermatology,
E G Jung, and
E Bohnert, and
E Fischer
February 2018,
Journal of dermatological science,
E G Jung, and
E Bohnert, and
E Fischer
January 1975,
Proceedings of the National Academy of Sciences of the United States of America,
E G Jung, and
E Bohnert, and
E Fischer
September 1991,
Mutation research,
E G Jung, and
E Bohnert, and
E Fischer
August 1986,
Photo-dermatology,
